Mice administered IFN-γ blocking antibodies have impaired humoral and cell-mediated immunity and significantly lower survival rates following influenza infection than IFN-γ-sufficient mice (Baumgarth and Kelso, 1996; Ishikawa et al., 2010). The gene discussed is IFNG; the disease is influenza.